Patent · US Active

Macrocyclic inhibitors of hepatitis C virus replication

US7829665B2 · kind B2 · utility

19Cited by

54References

29Claims

0Family size

Assignee

INTERMUNE, INC. · US

Inventors

Lawrence M. Blatt · San Francisco, US
Scott D. Seiwert · Pacifica, US
Steven W. Andrews · Longmont, US
Pierre Martin · Rheinfelden, CH
Andreas Schumacher · Weil am Rhein, DE
Bradley Barnett · Northglenn, US
C. Todd Eary · Longmont, US
Robert J. Kaus · Longmont, US
Timothy Kercher · Longmont, US
Weidong Liu · Superior, US
Michael Lyon · Boulder, US
Paul Nichols · Firestone, US
Bin Wang · Beijing, CN
Tarek Sammakia · Boulder, US
April L. Kennedy · Denver, US
Yutong Jiang · Boulder, US

Key dates

Filing date	Jul 21, 2006
Grant date	Nov 9, 2010
Priority date	—
Expiry date	Nov 15, 2026

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The embodiments provide compounds of the general Formulae I through general Formula VIII, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.